Ms. Linda Cubellis, M.ED., C.A.G.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16 Pine Street, Monument Beach, MA 02553 Phone: 508-846-5731 |
News Archive
New research finds that current national vitamin D intake recommendations are too low and that body weight must be taken into account to determine the appropriate vitamin D dose in any given individual. This is currently not the case, posing a serious Canadian public health issue with significant cost and health impacts.
Citing a federal government estimate that more than 3 million Californians cannot find doctors who will provide them essential medical care, health care and social justice advocates challenge the Senate to show the same level of compassion and leadership demonstrated by yesterday's passage of SB 726 (Ashburn) on the Assembly Floor.
MicroStockProfit.com announces an investment report featuring biopharmaceutical company Hemispherx Biopharma Inc. The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigeneā¢ C. difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon.
Bayer HealthCare announced today that the European Commission has granted marketing authorization for Xofigo (radium Ra 223 dichloride) solution for injection for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases. This decision follows a positive recommendation from the European Committee for Medicinal Products for Human Use in September of this year.
› Verified 1 days ago